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Abstract
Oxidative stress and inflammation contributed to the propagation of acute liver injury (ALI). The
present study was undertaken to determine whether D-galactosamine (D-GalN) induces ALI via
the mitochondrial apoptosis- and proinflammatory cytokine-signaling pathways, and possible
mechanism(s) by which green tea (GT) extract modulates the apoptotic and proinflammatory
signaling in rat. D-GalN induced hepatic hypoxia/hypoperfusion and triggered reactive oxygen
species (ROS) production from affected hepatocytes, infiltrated leukocytes, and activated Kupffer
cells. D-GalN evoked cytosolic Bax and mitochondrial cytochrome C translocation and activated
proinflammatory nuclear factor-kappa B (NF-κB) and activator protein-1 (AP-1) translocation,
contributing to the increase of intercellular adhesion molecule-1 expression, terminal
deoxynucleotidyl transferase-mediated nick-end labeling (TUNEL)-positive hepatocytes, multiple
plasma cytokines and chemokines release, and alanine aminotransferase (ALT) activity. An altered
biliary secretion profile of several acute phase proteins directly indicates oxidative stress affecting
intracellular trafficking in the hepatocyte. GT pretreatment attenuated ROS production,
mitochondrial apoptosis- and proinflammatory cytokine-signaling pathway, plasma ALT and
cytokines levels, biliary acute phase proteins secretion and hepatic pathology by the enhancement
of anti-apoptotic mechanisms. In conclusion, D-GalN induced ALI via hypoxia/hypoperfusion-
enhanced mitochondrial apoptosis- and proinflammatory cytokine-signaling pathway, contributing
to oxidative stress and inflammation in the liver. GT can counteract the D-GalN-induced ALI via
the attenuation of apoptotic and proinflammatory signaling by the upregulation of anti-apoptotic
mechanism.
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Background
Acute liver injury (ALI) may cause dismal clinical out-
come [1,2], but the detailed pathophysiologic mecha-
nisms and the preventive and therapeutic medications
have not been fully elucidated. In all types of liver damage
there is consistent evidence of enhanced oxidative stress
and/or significant decrease of antioxidant defense [2].
Oxidative stress and inflammation have been reported to
contribute to the pathogenesis of alcohol-, CCl4-, thioa-
cetamide- and endotoxin-induced ALI [2-6]. D-galactos-
amine (D-GalN) treated livers have metabolic and
morphological aberrations similar to those observed in
human viral hepatitis that always caused peri-portal
necro-inflammation [7,8] and hepatocyte apoptosis [9].
Although D-GalN was well-known to induce toxicity by
blocking RNA and protein synthesis [7,8], its ability to
induce oxidative injury in the liver was still poorly deline-
ated.
Reactive oxygen species (ROS) play a crucial role in the
induction and in the progression of liver disease. In
response to hypoxia/hypoperfusion or toxic injury, a mas-
sive ROS production can cause lipid peroxidation of cellu-
lar membranes, and protein and DNA oxidation, which
results in cellular injury [2,10-14]. The main sources of
ROS may derive from the mitochondria of hepatocytes,
the activated macrophages (Kupffer cells), and the infil-
trating neutrophils [2,11-14]. These ROS can trigger the
translocation of nuclear factor-kappa B (NF-κB) and acti-
vator protein-1 (AP-1) to nucleus [12] and activation of
inflammatory cytokines, chemokines, and adhesion mol-
ecules that, in turn, can contribute to further production
of ROS [2,6,14] and consecutively activate the cascade of
Bax and cytochrome c translocation and caspases (apop-
tosis) [15]. Various kinds of antioxidants capable of
decreasing NF-κB activity, ameliorating mitochondrial
dysfunction, cytochrome c release and caspase-3-medi-
ated apoptosis, and decreasing inflammatory cell infiltra-
tion [2-5,15-17] have been shown to reduce tissue injury.
Recently, the ROS enhanced proinflammatory NF-κB, AP-
1, and intercellular adhesion molecule-1 (ICAM-1)
expression as well as promoted proapoptotic mecha-
nisms, including increases in the Bax/Bcl-2 ratio, in
CPP32 expression, in poly-(ADP-ribose)-polymerase
(PARP) cleavages, and in DNA fragmentation and apop-
totic cells in the liver can be inhibited by the GT extract
supplement [12]. The cotreatment of epigallo-catechin
gallate resulted in the complete protection of the hepato-
cyte apoptosis suppressing the increases of caspase-3 in
the cytoplasm [12]. In addition, GT extract supplement
palliated plasma HOCl activity more effectively than vita-
min C [18]. GT extract also displayed dose-response
effects on palliating hemodialyis-enhanced plasma H2O2
and HOCl activities, lipid peroxidation (hosphatidylcho-
line hydroperoxide) production, C-reactive protein and
proinflammatory cytokines expression, and restored
paraoxonase 1 activity [18].
Therefore, we hypothesize that catechins, may prevent or
ameliorate ALI-associated apoptosis and inflammation
induced by a toxin such as D-GalN. In the present study,
we proved that D-GalN could induce ALI via promoting
mitochondrial apoptosis and modulating proinflamma-
tory cytokine-signaling pathways, and such detrimental
effects could be abolished by GT extract supplement.
Methods and materials
Animals
Female Wistar rats (200–250 g) were housed at the Exper-
imental Animal Center, National Taiwan University. All
surgical and experimental procedures were approved by
the animal care and experimental protocols were in
accordance with the guidelines of the National Science
Council of the Republic of China (NSC 1997).
The rats were anesthetized with subcutaneous urethane
(Sigma, St. Louis, MO, USA, 1.2 g/kg). D-GalN (Sigma, St.
Louis, MO, USA) was injected intraperitoneally at a dose
of 400 mg/kg body weight. The arterial blood pressure
and bile flow were measured [12]. At the end of each
experiment, the animals were sacrificed with overdose
anesthetics. Bile, plasma, and liver were stored at -70°C
until analyses.
Measurement of hepatic hemodynamics
Portal venous pressure (PVP), portal venous blood flow
(PVBF), and hepatic microvascular resistance were meas-
ured as described previously [12].
Measurement of hepatic O2 tension and hemodynamics
We monitored hepatic liver oxygenation in response to D-
GalN at the liver as previously described [12].
In vivo and in vitro chemiluminescence recording for ROS 
activity
The ROS generation in response to D-GalN-induced liver
injury was measured from the liver surface, bile, and
whole blood by a modified chemiluminescence detection
method, as described previously [11,12,15]. Briefly, the
ROS generation in response to D-GalN toxicity was meas-
ured from the liver surface by intravenous infusion of a
superoxide anion probe, 2-Methyl-6-(4-methoxyphenyl)-
3,7-dihydroimidazo- [1,2-a]-pyrazin- 3-one-hydrochlo-
ride (MCLA) (0.2 mg/ml/h, TCI-Ace, Tokyo Kasei Kogyo
Co. Ltd., Tokyo, Japan) and by the use of a Chemilumi-
nescence Analyzing System (CLD-110, Tohoku Electronic
In. Co., Sendai, Japan) [12]. The real-time displayed
chemiluminescence signal was indicated as ROS level
from the liver surface.Journal of Biomedical Science 2009, 16:35 http://www.jbiomedsci.com/content/16/1/35
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For evaluating the effects of antioxidants on oxidative
injury, identical experiments were performed in five rats
fed for two week with decaffeinated green tea extract (GT,
25–125 mg/kg), which is purchased from Numen Biotech
Co., Ltd., (Taipei, Taiwan) [12]. The GT extract was com-
posed of various types of catechins (328 mg/g of epigallo-
catechin gallate, 152 mg/g of epicatechin gallate, 148 mg/
g of gallocatechin gallate, 132 mg/g of epicatechin, 108
mg/g of epigallocatechin, 104 mg/g of galloctechin, and
44 mg/g of catechin), which is analyzed by high perform-
ance liquid chromatography (HPLC). The GT extract (25
and 125 mg) was dissolved in 500 mL of deionized dis-
tilled water every day. Each rat received restricted fresh
drink (100 mL/kg body weight) daily provided at 6:00
p.m. in each cage by using sealed bottles for 2 week. For
consistent dosage of GT extract, the rest of tea drink in
some rats was feed at 4:00 p.m. on the second day [12].
Analysis of catechins in rat plasma by using high 
performance liquid chromatography
The standard samples of epigallocatechin gallate, epicate-
chin gallate, gallocatechin gallate, epicatechin, epigallo-
catechin, galloctechin, and catechin were purchased from
Sigma Chemical Co. (St. Louis, MO). Oxalic acid, ethanol,
NaH2PO4 were purchased from Merck. Mobile Gradient
mobile phase A and B solution were from ESA Inc. (Bed-
ford, MA, USA). A standard stock mixture of epigallocate-
chin gallate, epicatechin gallate, gallocatechin gallate,
epicatechin, epigallocatechin, galloctechin, and catechin
at 100 μg/ml was prepared in 10 mM oxalic acid solution
and stored in small aliquots at -80°C until use. The stock
solutions remained stable for at least 6 months. The dis-
tribution of catechins in plasma and standards was deter-
mined by a gradient HPLC-Coulometric electrode array
system (ESA Inc., Bedford, MA, USA). One ml of rat
plasma samples was subjected to Al2O3 solid phase extrac-
tion (ESA Inc., Bedford, MA, USA), and the resulting sam-
ples in 1 M NaH2PO4 (pH = 2.5) were applied to the
HPLC with an autosampler (Model 542, ESA) and an elec-
trochemical detector (Model 5600A, ESA). The separating
conditions were as follows: column, HR-80 (C-18, 3 μm,
4.6 mm × 80 mm, ESA); column temperature, 25°C; gra-
dient mobile phase A (containing phosphate buffer and
an ion pairing agent, 45–0171, ESA) and gradient mobile
phase B (containing methanol, phosphate buffer, and an
ion pairing agent, ESA); flow rate, 1 mL/min. The option-
ally channel potential was set to 220 mV. The peak height
was used to calculate the plasma concentration using an
external calibration curve of spiked control plasma as
described previously in our laboratory [18]. The rat
plasma epigallocatechin gallate (10.1 ± 0.3 ng/mL or 13.2
± 1.2 ng/mL), epicatechin gallate (5.1 ± 0.6 ng/mL or 6.3
± 0.9 ng/mL), gallocatechin gallate (4.9 ± 0.7 ng/mL or
5.7 ± 0.8 ng/mL) were detected, but epicatechin, epigallo-
catechin, galloctechin, and catechin were not detected in
the rats with 25 mg/500 mL or 125 mg/500 mL GT extract.
Two-dimensional electrophoresis
Bile is secreted by hepatocytes, therefore, bile proteomic
profile may be provided more specific information and
protein markers of the hepatic responses to D-GalN-
induced injury and GT effects. The collected bile was ana-
lyzed by two-dimensional electrophoresis (2-DE) gel
techniques. Isoelectric focusing was performed with 13-
cm immobilized pH gradient strips pH 3–10 (IPG strips,
Amersham Bioscience) using the diffusion approach for a
total of 33 kVh (IPGphor II, Amersham Bioscience) at
20°C. Gels were stained with a modified silver nitrate pro-
cedure [19] according to the manufacturer's instructions
(Amersham Bioscience). The silver nitrate stained protein
spots were excised and subjected to in-gel tryptic digestion
as the previously described [20].
Peptide analysis by mass spectrometry
Zip-Tip cleaned samples were mixed with saturated α-
cyano-4-hydroxycinnamic acid solution in acetonitrile/
H2O and spotted onto a matrix-assisted laser desorption/
ionization (MALDI) sample plate. MALDI time-of-flight
mass spectrometry (MALDI-TOF MS) analysis was per-
formed on a Voyager DE-STR workstation (PerSeptive Bio-
systems, Framingham, MA, USA) equipped with a 337 nm
nitrogen laser. The peptide mass fingerprint data were
compared to those in the NCBInr protein database using
the Mascot searching tool http://www.matrixscience.com.
Protein identification was performed using Peptide Search
from the Mascot searching tool. Search parameters
included: Database, NCBInr; taxonomy, Homo sapiens;
enzyme, trypsin; peptide charge, 1+; instrument, MALDI-
QUAD-TOF.
Electrophoretic Mobility Shift Assay (EMSA)
The nuclear extracts from liver samples were obtained
with a nuclear extraction kit (Panonics, Inc. Redwood
City, CA, USA). Nine μg of nuclear extracts were analyzed
by using a commercially Electrophoretic-Mobility Shift
Assay (EMSA, Panonics, Inc.) for identifying NF-κB and
AP-1 that interacts with DNA. The EMSA procedure was
followed according to the manual and final results were
obtained by using a chemiluminescence imaging system
[12].
Western blot analysis
Cytosolic Bax translocation to mitochondria and mito-
chondrial leakage of cytochrome C to cytosol are required
for triggering apoptotic pathway [17]. The livers were sub-
jected to differential centrifugation to obtain the mito-
chondrial and cytosolic fractions. Ten μg of protein was
electrophoresed as described below. The primary anti-
body was a polyclonal rabbit antihuman cytochrome CJournal of Biomedical Science 2009, 16:35 http://www.jbiomedsci.com/content/16/1/35
Page 4 of 14
(page number not for citation purposes)
and heat shock protein 60 (HSP60) goat polyclonal anti-
body (Santa Cruz Biotechology, Inc., Santa Cruz, CA,
USA) used at 1:1000 or Bax (Chemicon, Temecula, CA,
USA).
We measured the expression of intercellular adhesion
molecule-1 (ICAM-1), Bax, Bcl-2, caspase 3, PARP [12],
and sterol regulatory element binding protein-1 (SREBP-
1) in the total protein from livers subjected to D-DalN-
induced injury. We also measured the expression of trans-
ferring and haptoglobin in the bile from livers subjected
to D-DalN-induced injury.
Antibodies raised against ICAM-1 (R&D systems, Inc.,
Minneapolis, MN, USA), Bax (Chemicon, Temecula, CA,
USA), Bcl-2 (Transduction, Bluegrass-Lexington, KY,
USA), the activation fragments (17 kD of cleaved product)
of caspase 3 (CPP32/Yama/Apopain) (Upstate Biotech-
nology, Lake Placid, NY, USA), PARP (Promega, Madison,
WI, USA), SREBP-1 (Santa Cruz Biotechnology, Inc., Santa
Cruz, CA, USA), transferrin (Santa Cruz), haptoglobin
(Abcam, Cambridge, UK) and β-actin (Sigma, St. Louis,
MO, USA) were used. Proteins on SDS-PAGE gels were
transferred to nitrocellulose filters and stained as
described [12].
Immunocytochemistry for oxidative stress and apoptosis
A nitroblue tetrazolium (NBT, Sigma, St. Louis, MO, USA)
perfusion method was used for localizing de novo ROS
generation in the liver [11,12,15]. The NBT-perfused liver
was removed and fixed in zinc/formalin solution and
processed for histologic examination of formazan depos-
its. The value of blue NBT deposits/total section area was
counted by Adobe Photoshop 7.0.1 image software anal-
ysis.
We also performed anti-4-hydroxy-2-nonenal (4-HNE)
antiserum (Alpha Diagnostic International, Inc., San
Antonia, TX, USA) and terminal deoxynucleotidyl trans-
ferase-mediated nick-end labeling (TUNEL) method [12]
to determine the presence and extent of apoptotic cells as
evidence of oxidative stress. The tissue sections (5 μm) of
the liver were prepared, deparaffinized, and stained by the
methyl green, 4-HNE- and TUNEL-avidin-biotin-complex
method. Twenty high-power (× 400) fields were ran-
domly selected for each liver section, and the value of
apoptotic cells/(apoptotic cells and methyl green stained
cells) was counted.
For hepatic Kupffer cell (ED1) staining, the tissue sections
were incubated overnight at 4°C with a mouse anti-rat
antibody to ED1 (CD68, 1:200, Serotec, Sydney, NSW,
Australia). A biotinylated secondary antibody (Dako, Bot-
any, NSW, Australia) was then applied followed by
streptavidin conjugated to horse peroxidase (Dako). The
chromogen used was Dako Liquid diaminobenzene.
Twenty high-power (× 200) fields were randomly selected
for each liver section, and the value of ED1 positive cells
was counted.
Biochemical analysis
The plasma alanine aminotransferase (ALT) level was
determined by use of a commercially available analytical
kit (Sigma, St. Louis, MO, USA). Bile concentrations of
transferrin and haptoglobin, two representative biomark-
ers, were selected and measured with Rat transferrin ELISA
Kit (Wako) and Rat haptoglobin ELISA Kit (Wako).
Multiple cytokine antibody arrays
In response to toxicity, several inflammatory mediators
such as cytokines and chemokines could be released by
activated macrophages/Kupffer cells in the damaged liver
or activated blood monocytes. Therefore, multiple
cytokine-expression levels were simultaneously deter-
mined and identified by use of RayBio®rat cytokine pro-
tein arrays (RayBiotech, Inc., Norcross, GA, USA)
according to the manufacturer's instructions.
Statistical analysis
All values were expressed as mean ± standard error of the
mean. Differences within groups were evaluated by paired
t-test. One-way analysis of variance was used for examin-
ing differences among groups. Inter-group comparisons
were made with Duncan's multiple-range test. A P value of
< 0.05 was considered to indicate significance.
Results
Effect of D-GalN on hepatic hemodynamics
Within 6 hr post treatment of D-GalN, a decrease in PVBF,
liver oxygenation, and bile flow and an increase in hepatic
vascular resistance are demonstrated (Figure 1), indicating
a hypoxia/hypoperfusion condition induced by D-GalN.
D-GalN increased ROS in liver, bile, and blood
Intravenous infusion of MCLA measured to a baseline
level of superoxide-dependent ROS counts in a range of
1500–2200 counts (Figure 2). Upon D-GalN administra-
tion, the level of O2 
-.-dependent ROS from the liver sur-
face started to increase within 6 hr and was maintained at
high level at 24–72 hrs. Hepatic ROS production was
accompanied by increased O2 
-. and H2O2 production in
the bile within 6 hr of D-GalN treatment (Figure 2). The
hepatic ROS, biliary O2 
-. and H2O2, and blood O2 
-. and
H2O2 were consistently elevated at 24–72 hrs (Figure 3).
However, the increased level of hepatic, biliary, and whole
blood ROS was significantly reduced by the pretreatment
with GT. The increased plasma ALT level was also
depressed by the GT pretreatment.Journal of Biomedical Science 2009, 16:35 http://www.jbiomedsci.com/content/16/1/35
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Effect of D-GalN on proinflammatory and apoptosis-
regulated gene expression
ROS triggered early cellular signal transduction pathways
responsible for the activation of NF-κB and AP-1, resulting in
up-regulation of the ICAM-1 gene in the insulted tissue [12].
The proinflammatory response of NF-κB and AP-1 transloca-
tion and the ICAM-1 protein expression in the livers sub-
jected to D-GalN is displayed in Figure 4. Significant hepatic
nuclear binding of transcription factor NF-κB and AP-1 was
observed in the D-GalN liver. The enhanced hepatic NF-κB
and AP-1 binding activity was partly inhibited by GT pre-
treatment (Figure 4A). The ICAM-1 expression was increased
by D-GalN treatment (Figures 4B &4C). The increased proin-
flammatory responses were inhibited by GT pretreatment.
Similar to the proinflammatory response, the proapoptotic
signaling pathway was also enhanced by D-GalN intoxica-
tion. D-GalN activated Bax translocation to mitochondria
and cytochrome C translocation to cytosol in the livers
(Figure 5A). The expression of Bax, Bcl-2, CPP32, and PARP
in the total proteins of liver after D-GalN was assessed by
immunoblotting with antibodies against Bax, Bcl-2,
CPP32, and PARP (Figure 5B). The ratio of Bax/Bcl-2 and
the expression of 17 kD (cleaved product) of CPP32 and
PARP were all increased in D-GalN livers. Similar to the
proapoptotic response, the lipogenic enzyme expression,
SREBP-1, was also enhanced after D-GalN treatment. The
enhanced proapoptotic and lipogenic signaling could be
suppressed by GT pretreatment.
D-GalN effect on hepatic Kupffer cells, 4-HNE stains and 
apoptotic cell death
Significant lipid accumulation was detected in helatocytes
24–72 hrs after D-GalN treatment (Figure 6). GT pretreat-
ment reduced the appearance of fatty liver (Figure 6C).
A NBT and 4-HNE staining was employted to localize the
exact site of ROS generated in the liver. NBT deposits (O2
Mean values of arterial blood pressure (ABP), portal venous  pressure (PVP), portal venous blood flow (PVBF), hepatic  oxygen tension (PO2), hepatic vascular resistance (HVR), and  bile flow at different time in response to D-GalN treatment Figure 1
Mean values of arterial blood pressure (ABP), portal 
venous pressure (PVP), portal venous blood flow 
(PVBF), hepatic oxygen tension (PO2), hepatic vascu-
lar resistance (HVR), and bile flow at different time 
in response to D-GalN treatment. In D-GalN rats (n = 
6), D-GalN significantly decreased the PVBF, PO2, and bile 
flow and increased HVR. In normal rats (n = 6), the hepatic 
vasoconstrictor effect was not found. * P < 0.05 vs. the con-
trol value (C). # P < 0.05 D-GalN vs. Normal.
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Low dose and high dose of green tea extracts (GT) effects on liver reactive oxygen species (ROS), bile lucigenin (LC) and lumi- nol (LM) ROS, blood LC and LM ROS, and plasma alanine aminotransferase (ALT) in D-galactosamine treated rats Figure 3
Low dose and high dose of green tea extracts (GT) effects on liver reactive oxygen species (ROS), bile luci-
genin (LC) and luminol (LM) ROS, blood LC and LM ROS, and plasma alanine aminotransferase (ALT) in D-
galactosamine treated rats. * P < 0.05 vs. control value (C). # P < 0.05 between D-GalN and GT treatment.
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-. generation) did not appear in the livers of control rats
(Figure 6D). There was a significant increase in blue for-
mazan deposits in the liver at 24 hr post D-GalN treat-
ment (Figure 6E). The NBT deposits were found in both
Kupffer cells (ED1 stain) and hepatocytes.
There was a significant increase in protein oxidation pro-
duction (brown deposits) in the liver at 24 hr post D-
GalN treatment (Figure 6H). The 4-HNE stains were
mainly found in the hepatocytes.
ROS oxidized macromolecules and contributed to apop-
tosis [12,15]. Apoptotic cells were not detected in sections
from the control rat liver (Figure 6J). In contrast, apop-
totic nuclei were readily be detected in hepatocytes of D-
GalN treated livers (Figure 6K). When pretreatment with
GT was performed, liver hepatocytes displayed a signifi-
cant decrease in lipogenic accumulation (Figure 6C), ED-
1 (Figure 6F), 4-HNE (Figure 6I), and TUNEL stains (Fig-
ure 6L).
Influence of D-GalN on bile proteomics
For proteomic analysis, 5-μl bile samples from control
rats (n = 3), D-GalN rats (n = 5), GT pretreated-D-GalN
rats (n = 5) were subjected to 2-DE and proteins visualized
by silver staining.
Figure 4A shows representative silver stained 2-DE gels of
control, D-GalN24 hr, and D-GalN24 hr+GT pretreat-
ment. As shown in Table 1, the protein parameters and the
amount of six major proteins identified included transfer-
rin; polymeric immunoglobin A receptor; acute phase α-1
protein; kallikrein binding protein; haptoglobin; and Ig α-
chain. After 24 hr post D-GalN treatment, the major bil-
iary proteins, except for hepatoglobin, were increased
(Figure 7A). Western blotting (Figure 7B) and ELISA anal-
ysis (Figure 7C) confirmed the increased transferrin and
decreased haptoglobin level and supported that GT extract
pretreatment reduced D-GalN-induced hepatocytes
impairment.
Influence of D-GalN on plasma multiple cytokines
Figure 8 depicts multiple cytokines determination by
means of cytokine antibody array in the plasma. The
mean changes (indicated by ratios of control) of 6 repre-
sentative cytokines, CINC-3, CNTF, MCP-1, MIP-3α,
TIMP-1, and TNF-α were increased after D-GalN intoxica-
tion. GT pretreatment significantly depressed the increase
of these six plasma cytokine and chemocytokines. Other
13 cytokines indicated from a to m were also measured
simultaneously in the plasma. We found that the level of
13 cytokines is not increased after D-GalN treatment
when compared to control, but seems to be depressed
after GT treatment.
Discussion
The present study demonstrates that intraperitoneal appli-
cation of D-GalN induced hepatic sympathetic nerve acti-
vation induced hypoxia/hypoperfusion, and increased
liver and bile ROS production, hepatocyte apoptosis and
proinflammatory cytokines via mitochondrial apoptosis-
and proinflammatory cytokine-signaling pathway. GT
pretreatment protected against ROS toxicity via enhanced
anti-apoptotic mechanism to reduce proinflammatory
cytokines and proapoptotic mechanisms in the D-GalN-
induced ALI.
Formation of ROS occurs in a variety of forms of liver
injury [10-14]. In our study, an early event (within 6 hr)
A: The analysis of nuclear factor NF-κB and AP-1 from the  nuclear extracts of liver samples at 6 hr of D-GalN treatment  were performed with a nuclear extraction kit and using a  commercially Electrophoretic-Mobility Shift Assay Figure 4
A: The analysis of nuclear factor NF-κB and AP-1 
from the nuclear extracts of liver samples at 6 hr of 
D-GalN treatment were performed with a nuclear 
extraction kit and using a commercially Electro-
phoretic-Mobility Shift Assay. The induction of nuclear 
factor NF-κB and AP-1 nuclear factors by D-GalN treatment 
is partly inhibited by green tea (GT) pretreatment.B: Immu-
noblot analyses for specific antibodies to ICAM-1, and β-actin 
were performed in livers taken at 6 hr after D-GalN treat-
ment. Note the increased expression of ICAM-1 in response 
to D-GalN. C: The enhanced expressions of these specific 
proteins were significantly reduced by GT pretreatment. 
Equal protein loading was displayed by β-actin. * P < 0.05 vs. 
control value. # P < 0.05 vs. D-GalN treatment.Journal of Biomedical Science 2009, 16:35 http://www.jbiomedsci.com/content/16/1/35
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seen after administration of D-GalN is an accumulation
of neutrophils and Kupffer cells in the liver sinusoids
and an elevation of hepatic and bile ROS. The overpro-
duced ROS may contribute to hepatic apoptotic cell
death. Mitochondria are the target and source of ROS
[21], which play an important role in physiologic signal-
ing mechanisms and in regulation of apoptotic pathway
[22]. Mitochondrial dysfunction disrupts mitochondrial
membrane potential (MTP) for ATP synthesis and trig-
gers oxidative and anoxic cell death [23]. The outer mito-
chondrial voltage-dependent anion conductance
(VDAC) channel is involved in cytochrome c release and
is regulated by ROS and Bcl-2 family [24,25]. O2
-. but not
H2O2 induces VDAC-dependent permeabilization of the
outer mitochondrial membrane in HepG2 cells [24]. Bcl-
2 family is able to regulate the status of MTP; Bax, a chan-
nel-forming protein, can open it [26], and Bcl-2 and Bcl-
xL are able to stabilize and inhibit its opening [27].
Release of cytochrome c is a proximate trigger for evok-
ing caspase 3 mediated apoptosis [24,25]. Therefore, an
increase in ROS and a reduction in Bcl-2/Bax ratio
enhance cytochrome c release, and caspase 3 mediated
apoptosis [22]. Presently, the decreased ratio of Bcl-2/
Bax by D-GalN injury triggers O2
-. production, Bax trans-
location to mitochondria, cytochrome c release to cyto-
plasm, CPP32 activation, and increases PARP fragments
initiated apoptosis.
In addition to the apoptotic signaling, the overproduced
ROS triggered early cellular signal transduction pathways
responsible for the activation of NF-κB and AP-1, result-
ing in up-regulation of the ICAM-1 gene in the vascular
endothelium and tissue accumulation of activated neu-
trophil accumulation [12]. Likewise, we demonstrated
that the damaged liver initiated by D-GalN evoked a burst
in the release of ROS that led to early activation of nuclear
translocation of the p65 subunit of NF-κB and AP-1,
which, in turn, promotes the expression of ICAM-1 pro-
tein. This proinflammatory response can be abrogated by
GT, which exert antioxidant (scavenging ROS activity) and
anti-inflammatory activity (decreasing NF-κB, AP-1, and
ICAM-1) on D-GalN enhanced oxidative stress.
In response to oxidative injury or inflammation, acute
phase response is initiated [28] and acute phase proteins
are predominantly synthesized and secreted by the liver
[29]. These acute phase proteins include the polymeric
IgA receptor, which is transported from the blood through
the transcytotic pathway, transferrin (a hepatocyte-syn-
thesized species involved in uptake by receptor-mediated
endocytosis and considered a recycling protein), and hap-
toglobin, which is delivered from the hepatocyte lyso-
somal compartment [30,31]. D-GalN increases the biliary
level of transferrin in the endosomal recyling compart-
ment and polymeric IgA receptor in the endosomal tran-
A: Green tea (GT) extracts inhibit the mitochondrial apoptosis-signaling pathway Figure 5
A: Green tea (GT) extracts inhibit the mitochondrial apoptosis-signaling pathway. The cytosolic and mitochondrial 
fractions were prepared at 6 hr after D-GalN from the livers and subjected to western blot analysis for Bax and cytochrome c 
(Cyt c), respectively. Note that GT treatment decreased the D-GalN-induced cytosolic Bax translocation to mitochondria and 
accumulation of Cyt c in the cytosol. B: Low dose (LGT) and high dose (HGT) of GT decreased D-GalN enhanced proapop-
totic Bax/Bcl-2 ratio, CPP32 and PARP expression, and lipogenic enzyme (SREBP-1) in the liver subjected to 1–3 days of D-
GalN intoxication.Journal of Biomedical Science 2009, 16:35 http://www.jbiomedsci.com/content/16/1/35
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Leukocytic infiltration (indicated by green arrows, B-C), lipogenic accumulation (indicated by stars *, B, H, K), nitroblue tetra- zolium (NBT) deposits (blue precipitate indicated by green arrows, E), hepatic Kupffer cell (ED1) stain (brown stain, D-F), 4- hydroxy-2-nonenal (4-HNE) stain (brown color, H), and terminal deoxynucleotidyl transferase-mediated nick-end labeling  (TUNEL) stain were used to demonstrate de novo production of oxidative stress in the D-GalN treated liver Figure 6
Leukocytic infiltration (indicated by green arrows, B-C), lipogenic accumulation (indicated by stars *, B, H, K), 
nitroblue tetrazolium (NBT) deposits (blue precipitate indicated by green arrows, E), hepatic Kupffer cell 
(ED1) stain (brown stain, D-F), 4-hydroxy-2-nonenal (4-HNE) stain (brown color, H), and terminal deoxynucle-
otidyl transferase-mediated nick-end labeling (TUNEL) stain were used to demonstrate de novo production of 
oxidative stress in the D-GalN treated liver. Oxidative stress indicated by NBT (green arrows) appeared in the Kupffer 
cells (identified by ED1 brown color) and hepatocytes of rat livers subjected to 24 hr of D-GalN treatment (E), but less evident 
in the control liver (D) and the liver with low dose of GT pretreatment (F). 4-HNE stain for oxidized protein concomitantly 
occurred in the D-GalN treated hepatocyte with lipogenic accumulation (H), but not appeared in the control (G) or GT pre-
treated livers (I). TUNEL stain for apoptotic cell death was absent in the control liver (J) and GT treated liver (L), but 
appeared in the liver after 24 hr of D-GalN treatment (K). A-C, hematoxylin and eosin stain, × 400; D-F, NBT+ED1 counter-
stain, × 400; G-I, 4-HNE stain, × 600;J-L, TUNEL stain, × 400.Journal of Biomedical Science 2009, 16:35 http://www.jbiomedsci.com/content/16/1/35
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A: 2-D PAGE electrophotogram of bile Figure 7
A: 2-D PAGE electrophotogram of bile. B: Western blotting analysis of transferring and haptoglobin.C: ELISA data of bile. 
Electrophotogram were obtained by silver nitrate staining. The approximate molecular weight (MW) and PI values are as indi-
cated. There were six proteins, spots 1 to 6, with the most striking differences between the control and 24 h after D-GalN 
treatment (D-GalN24) bile proteome. All of these protein spots (spots 1–6) were subsequently analyzed by MS for protein 
identification. Whereas transferring (spot 1), polymeric IgA receptor (spot 2), and kallikrein-binding protein (spot 4) expres-
sion enhanced at 24 hr and still maintained at high level at 72 hr, the haptoglobin (spot 5) decreased at 24 hr but returned to 
control levels at 72 hr post D-GalN treatment. Spot 1, transferring; spot 2, polymeric IgA receptor; spot 3, acute phase α-1 
protein; spot 4, kallikrein-binding protein; spot 5, haptoglobin; spot 6, Ig α chain. Detailed data is described in Table 1.
* P < 0.05 vs. C group; a P < 0.05 D-GalN+LGT vs. D-GalN; b P < 0.05 D-GalN24+HGT vs. D-GalN24+LGT  
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scytotic compartment, but decreases that of haptoglobin
in lysosomal compartment. These data indicate for the
first time that intracellular trafficking of hepatocytes is
altered after D-GalN-induced injury.
On the other hand, the acute phase response is also medi-
ated partly by a set of inflammatory mediators such as
cytokines and chemokines, which are released by acti-
vated macrophages/Kupffer cells or blood monocytes. The
liver is the principal target of systemic inflammatory
mediators and is the organ responsible supplying the nec-
essary components for tissue damage, for removing harm-
ful agents, and for tissue repair [29]. We have used
cytokine arrays in the present study, because RayBio®rat
cytokine protein arrays are more sensitive and offer higher
throughput then the conventional ELISA and Western
blotting method [32]. We found that six plasma cytokines
and chemokines were elevated after 24 hr of D-GalN
intoxication. Two of these (CINC and MIP) are members
of the CXC chemokine family, are potent chemotactic fac-
tors for neutrophils [33], and contribute to neutrophil
recruitment in inflammation [34]. Another affected
cytokine (CNTF) is a member of the interleukin-6 (IL-6)
superfamily, and is involved in fever induction and a
hepatic acute phase protein response [35]. CNTF is
removed from the circulation by the liver. Probably as a
consequence of hepatocyte binding, CNTF induces acute-
phase responses and inflammatory side effects in the liver
[36]. A fourth elevated cytokine (MIP-3α) is expressed
mostly in the liver and is produced by periportal dendritic
cells and/or macrophages after necroinflammatory
response, leading to the recruitment of activated T cells
into the liver [37]. The plasma concentrations of the final
two elevated cytokines (TIMP-1 and TNF-α) are signifi-
Table 1: Protein identified in rat bile by 2-D electrophoresis
Spot ID Accession no. Protein name Protein score Search engine Molecular weight (Da) Regulation 
(D-GalN24/Control)
MASCOT
1 gi|6175089 Serotransferrin precursor 
(Transferrin) (Siderophilin) (β-1-
metal binding globulin)
52 MASCOT 76314 Increased
2 gi|27151742 Polymeric immunoglobulin 
receptor; polymeric IgA 
receptor [Rattus norvegicus]
51 MASCOT 84745 Increased
3 gi|68791 Major acute phase α 1-protein 
precursor-rat (fragment)
48 MASCOT 46935
4 gi|92335 Kallikrein-binding protein 
precursor-rat
59 MASCOT 46490 Increased
5 gi|123513 Haptoglobin precursor 84 MASCOT 38525 Decreased
6 gi|204720 Ig α-chain 61 MASCOT 15594
MASCOT is a one of the search engine offered by Matrix Science.
Determination of multiple cytokines determination by  cytokine antibody array in the plasma from control, 24 hr  after D-GalN treatment, and 24 hr of after D-GalN and  green tea (D-GalN+GT) pretreatment Figure 8
Determination of multiple cytokines determination 
by cytokine antibody array in the plasma from con-
trol, 24 hr after D-GalN treatment, and 24 hr of after 
D-GalN and green tea (D-GalN+GT) pretreatment. 
The plasma cytokine profiles are displayed in A. The mean 
changes (indicated by ratios of control) of 6 cytokines (n = 3) 
are displayed in B. 1, positive control; 2, negative control; 3, 
CINC-3; 4, CNTF; 5, MCP-1; 6, MIP-3α; 7, TIMP-1; 8, TNF-
α. *P < 0.05, vs. control group. a, cytokine-induced neu-
trophil chemoattractants-2; b, Fractalkine; c, granulocyte 
macrophage colony-stimulating factor; d, interferon-γ; e, 
interleukin-1α; f, interleukin-1β; g, interleukin-4; h, inter-
leukin-6; I, interleukin-10; j, lipopolysaccharide-induced CXC 
chemokine; k, Leptin; l, β-nerve growth factor; m, vascular 
endothelial growth factor. # P < 0.05, vs. D-GalN group.
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cantly increased in patients with fulminant hepatitis,
reflecting severe hepatic inflammation [38]. Inhibition of
the nuclear translocation of NF-κB and the reduction of
expression of MIP and MCP-1 abrogates hepatitis C virus-
infected liver induced leukocyte infiltration [39]. Moreo-
ver, we recently demonstrated that GT supplementation
markedly attenuates the ROS enhanced proinflammatory
NF-κB and AP-1 translocation, ICAM-1 expression, and
caspase 3 activity and apoptosis formation in the rat liver
[12]. In human study, GT extract supplement palliated
plasma HOCl activity more effectively than vitamin C and
displayed dose-response effects on reducing inflamma-
tion-enhanced H2O2 and HOCl amounts, atherosclerotic
risk factor concentration, C-reactive protein and proin-
flammatory cytokines expression, and restored paraoxo-
nase 1 activity in high-density lipoprotein [18]. There is
no significant dosage effect on ROS level, apoptotic
expression in the molecular analysis, and inflammation
between low (25 mg) and high GT extract (125 mg) in our
study. The level of rat plasma epigallocatechin gallate
(10.1 ± 0.3 ng/mL or 13.2 ± 1.2 ng/mL), epicatechin gal-
late (5.1 ± 0.6 ng/mL or 6.3 ± 0.9 ng/mL), gallocatechin
gallate (4.9 ± 0.7 ng/mL or 5.7 ± 0.8 ng/mL) was similar
between 25 mg/500 mL and 125 mg/500 mL of GT sup-
plement. We therefore suggest that 25 mg of GT extract
may evoke a similar influence as well as 125 mg of GT to
reduce D-GalN-induced oxidative stress. Our results con-
firm the effects of GT and further demonstrated that anti-
oxidant and anti-inflammatory GT activities reduce D-
GalN enhanced plasma proinflammatory cytokines.
D-GalN or alcohol is well known substances which pro-
duce toxic liver damage in animal experiments. Of spe-
cial significance is the toxic fatty infiltration in the live
parenchyma of these models [2,6]. Oxidative stress orig-
inating from overexpression of an active form of SREBP-
1 and increased intracellular levels of fatty acids has also
been implicated as a cause of hepatocellular injury in
steatosis [40]. Our data shows that D-GalN induced fatty
acid production in the liver, possibly via the elevation of
SREBP-1 protein expression. Immunocytochemical anal-
ysis revealed the concomitant accumulation of 4-HNE
and lipogenic products in D-GalN treated liver. Amelio-
ration of hepatic steatosis caused by SREBP-1 gene dis-
ruption in ob/ob mice lowers triglyceride content [41]. A
diet enriched in fish oil can downregulate lipogenesis by
decreasing liver SREBP-1, suppressing endogenous PPA-
Rαactivation, and increasing antioxidant gene expres-
sion, thereby protecting against ROS excess [42].
Presently, we demonstrate that GT markedly decreases
the mature form of SREBP-1 protein and reduces the
expression of lipid accumulation in the D-GalN treated
rats. GT ameliorates hepatic steatosis, presumably
through downregulation of oxidative stress enhanced
SREBP-1.
Using antioxidants such as vitamins E and C or ROS scav-
engers such as catalase or superoxide dismutase prevented
acute hepatocellular damage [42]. Previously, the apop-
totic protection of epigallo-catechin gallate, a major com-
ponent of catechins, was via the suppression of the
elevated caspase-3 in the cytoplasm [12]. The present
study demonstrates low and high doses of GT offered
direct and indirect protection in reduction of plasma ALT
and cytokine levels, improved liver histology, preserved
antioxidant and anti-apoptotic protein content, and
decreased ROS production in the liver and bile from ani-
mals receiving GT compared with those receiving water.
The protection may be attributed to the antioxidant, anti-
apoptotic, and anti-inflammatory activity of GT in the
liver cells and in the interstitial space.
In conclusion, D-GalN induces ALI via mitochondrial
apoptosis- and proinflammatory cytokine-signaling path-
ways, subsequently leading to increases in ROS produc-
tion, hepatocyte apoptotsis, and plasma multiple
cytokines and chemokines. GT can counteract D-GalN-
induced mitochondrial apoptosis- and proinflammatory
cytokine-signaling pathways by the possible mechanisms
of a direct scavenging ROS activity and an upregulation of
antioxidant defense mechanisms.
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